Medicamen Biotech shareholding pattern

·Pharma & Health Chart ›

Who owns itOct 2026 quarter

Promoters42.57%

Foreign investors (FII)4.35%

Domestic institutions (DII)0.00%

of which mutual funds0.00%

Public53.03%

Per cent of all shares. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDICAMEQ₹254.25

Medicamen Biotech Limited

· Pharma & Health

₹ CrorePeersMEDICO AAREYDRUGS NECLIFE HALEOSLABS ALBERTDAVD NATCAPSUQ VALIANTLAB BALPHARMAMcap ₹345 Cr

Holding % of Total Shares 12 Months Ending	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	42.99	42.99	42.99	43.16	40.46	40.46	40.46	40.46	40.46	40.46
FII / FPI	0.06	0.06	0.05	0.12	0.00	0.06	0.02	0.10	0.07	4.49
DII	1.17	1.17	0.87	0.69	0.64	0.59	0.44	—	0.40	0.00

Latest: 2026-10-23 · 24 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.